Stephen Ubl — SPARQNOW

At-a-Glance

Serves as President and CEO at PhRMA since 2015.
Served as President and CEO at AdvaMed from 2005 to August 2015.
Leads PhRMA in representing the country’s leading innovative biopharmaceutical research companies.
Focuses on fostering a policy and regulatory environment that fuels medical innovation and strengthens the healthcare system.
Holds a Bachelor of Arts in Political Science/Speech.

Biography

Stephen Ubl serves as the President and CEO of PhRMA, an organization representing leading innovative biopharmaceutical research companies. In this role since 2015, he leads efforts to discover and develop medicines that aim to enable patients to live longer, healthier, and more productive lives. Ubl emphasizes the importance of new medicines as an integral part of the healthcare system, providing safe and effective treatment options and improving quality of life.